Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Pancreatic Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01068327
What this trial is testing

Stereotactic Radiation, Nelfinavir Mesylate & Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasStage III Pancreatic Cancer
University of Nebraska 46
Not applicableEnded earlyNCT04136769
What this trial is testing

Preoperative/Neoadjuvant Therapy and Vascular Debranching Followed by Resection for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreas Cancer
Ulrich Ronellenfitsch, MD 3
Not applicableStudy completedNCT06195254
What this trial is testing

Stereotactic Body Radiotherapy Combined With PD-1 Blockers for Locally Advanced or Locally Recurrent Pancreatic Cancer

Who this might be right for
Stereotactic Body RadiotherapyPD-1 InhibitorsPancreatic Cancer
Peking University Third Hospital 19
Testing effectiveness (Phase 2)UnknownNCT00006117
What this trial is testing

Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Testing effectiveness (Phase 2)Active Not RecruitingNCT06412510
What this trial is testing

Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT

Who this might be right for
Ovarian CancerEpithelial Ovarian CancerPancreatic Adenocarcinoma
Case Comprehensive Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT01506973
What this trial is testing

Hydroxychloroquine in Combination With Gemcitabine/Abraxane in Pancreatic Cancer

Who this might be right for
Advanced AdenocarcinomaMetastatic Adenocarcinoma
Abramson Cancer Center at Penn Medicine 119
Testing effectiveness (Phase 2)UnknownNCT00323583
What this trial is testing

Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer

Who this might be right for
Adenocarincoma of PancreasStage III Pancreatic CancerStage IVA Pancreatic Cancer+1 more
Seattle Cancer Treatment and Wellness Center 80
Early research (Phase 1)Ended earlyNCT01050283
What this trial is testing

Evaluate [18F]-FDG PET (Fluorodeoxyglucose-positron) in Patients With Pancreatic Cancer (MK-0000-144)

Who this might be right for
Advanced Pancreatic Adenocarcinoma
Merck Sharp & Dohme LLC 15
Testing effectiveness (Phase 2)Study completedNCT03040986
What this trial is testing

Selumetinib Sulfate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer With KRAS G12R Mutations

Who this might be right for
KRAS NP_004976.2:p.G12RStage III Pancreatic Cancer AJCC v6 and v7Stage IV Pancreatic Cancer AJCC v6 and v7
National Cancer Institute (NCI) 8
Large-scale testing (Phase 3)Study completedNCT00088894
What this trial is testing

Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage II Pancreatic Cancer+2 more
National Cancer Institute (NCI) 590
Early research (Phase 1)Ended earlyNCT05494866
What this trial is testing

A Trial of Cobicistat and Gemcitabine and Nab-Paclitaxel in Patients with Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
CYP3A InhibitorAdvanced Stage or Metastatic Pancreatic Ductal AdenocarcinomaPancreatic Cancer+2 more
German Cancer Research Center 6
Not applicableApproved For MarketingNCT04100694
What this trial is testing

Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor

Who this might be right for
NRG1 FusionPancreatic CancerNon Small Cell Lung Cancer+8 more
Merus B.V.
Testing effectiveness (Phase 2)Study completedNCT00363051
What this trial is testing

Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy

Who this might be right for
Islet Cell CarcinomaNeuroendocrine CarcinomaNeuroendocrine Tumor+1 more
Novartis Pharmaceuticals 160
Early research (Phase 1)UnknownNCT06094777
What this trial is testing

HY-0102 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Shanghai YingLi Pharmaceutical Co. Ltd. 50
Early research (Phase 1)UnknownNCT06081322
What this trial is testing

Evaluate the Safety and Efficacy of PRRT With 177Lu-EB-FAPI in Patients With Advanced Cholopancreatic Tumors

Who this might be right for
Advanced Pancreatic Cancer and Cholangiocarcinoma
Zhejiang University 29
Large-scale testing (Phase 3)Looking for participantsNCT03755739
What this trial is testing

Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors

Who this might be right for
HepatocarcinomaLung CancerMelanoma+7 more
Second Affiliated Hospital of Guangzhou Medical University 200
Testing effectiveness (Phase 2)Study completedNCT03443492
What this trial is testing

SLOG vs mFOLFIRINOX as the First-line Treatment in Locally Advanced Uncresectable or Metastatic Pancreatic Cancer

Who this might be right for
Locally Advanced or Metastatic Pancreatic Cancer
National Health Research Institutes, Taiwan 130
Testing effectiveness (Phase 2)UnknownNCT06396637
What this trial is testing

PD-1 Antibody and Sapropterin Dihydrochloride in Patients With PDAC

Who this might be right for
Pancreatic Adenocarcinoma Metastatic
Sun Yat-sen University 20
Not applicableAvailableNCT04091295
What this trial is testing

BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast

Who this might be right for
Pancreatic CancerOsteosarcomaMPNST (Malignant Peripheral Nerve Sheath Tumor)+6 more
Aveni Foundation
Testing effectiveness (Phase 2)Active Not RecruitingNCT07023731
What this trial is testing

Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation

Who this might be right for
KRAS G12D MutationAdvanced Solid Cancer
Arvinas Inc. 76
Next Page